https://www.selleckchem.com/products/nps-2143.html
This study aimed to evaluate the antioxidant and antidiabetic properties of clove essential oil (CEO) and to elucidate its mode of action, using selected biochemical targets, relevant to diabetes, and, specifically, its inhibitory effect on the polyol pathway. In the current study, CEO was examined for its inhibitory effects on aldose reductase in silico, in vitro, and in vivo, as well as its antioxidative activity. In silico docking studies showed that all the selected major compounds of CEO have an energy change ranging between - 5.5
Like
Comment
Share
